Literature DB >> 19174585

A prospective, descriptive study to identify the microbiological profile of chronic wounds in outpatients.

Somprakas Basu1, Tetraj Ramchuran Panray, Tej Bali Singh, Anil K Gulati, Vijay K Shukla.   

Abstract

Indiscriminate use of antibiotics for infected chronic wounds is a global problem that may contribute to delayed healing and the development of drug-resistant micro-organisms. A prospective, descriptive cohort study of 50 male and female outpatients (mean age 52.50 [+/- 14.84] years, range 18-90) with 52 chronic wounds was conducted to investigate the microbiological profile and prevalence of drug-resistant strains in chronic nonhealing wounds to develop an evidence-based approach to antibiotic therapy until drug sensitivity reports are available. Mean wound duration was 8.23 (+/- 12.35) months (range 1.5-72), average wound size was 29.70 (+/- 37.83) cm, and most patients had a lower extremity wound and diabetes mellitus (n = 20). Pus and tissue samples were cultured and tested. Most (45) wounds contained a single organism and nine different genera were isolated. Of those, 39 were Gram-negative and 11 were Gram-positive (z = 5.50, P = <0.001). The most common organisms were Pseudomonas (21 wounds) and Escherichia coli (eight wounds). Pseudomonas aeruginosa was more common in patients with diabetes mellitus, in lower extremity ulcers, and in ulcers >20 cm2 (z-test, P <0.05). The presence of two organisms was more commonly observed in postsurgical/traumatic wounds. Ten (10) out of 55 pathogens (18.18%) isolated were drug-resistant, including Pseudomonas (seven), methicillin-resistant Staphylococcus aureus (one), and extended-spectrum beta lactamase (two--E. coli and Citrobacter). Most (70%) drug-resistant pathogens were obtained from persons with diabetes mellitus. Overall sensitivity to piperacillin and tazobactum combination was high. Because the prevalence of monomicrobial flora in chronic wounds is high, if a wound infection is suspected, empiric therapy should target the most prevalent flora. The high rate of drug-resistant Pseudomonas and MRSA strains should discourage antibiotic use in chronic ulcers before obtaining culture results.

Entities:  

Mesh:

Year:  2009        PMID: 19174585

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  6 in total

1.  Prevalence and Antibiotic Resistance of Gram-Negative Pathogenic Bacteria Species Isolated from Periplaneta americana and Blattella germanica in Varanasi, India.

Authors:  D Leshan Wannigama; Rishabh Dwivedi; Alireza Zahraei-Ramazani
Journal:  J Arthropod Borne Dis       Date:  2013-12-18       Impact factor: 1.198

2.  Antibiotic susceptibility of wound isolates in plastic surgery patients at a tertiary care centre.

Authors:  Surendra B Patil; Amit Paramne; Shree Harsh
Journal:  Indian J Plast Surg       Date:  2016 May-Aug

3.  Methylene Blue-Mediated Antimicrobial ​Photodynamic Therapy Against Clinical Isolates of Extensively Drug Resistant ​Gram-Negative Bacteria Causing Nosocomial Infections in Thailand, An In Vitro Study.

Authors:  Chankiat Songsantiphap; Jakapat Vanichanan; Tanittha Chatsuwan; Pravit Asawanonda; Einapak Boontaveeyuwat
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

4.  Prevalence of Multiple Antibiotic Resistant Infections in Diabetic versus Nondiabetic Wounds.

Authors:  Urvish Trivedi; Shamini Parameswaran; Andrew Armstrong; Diana Burgueno-Vega; John Griswold; Sharmila Dissanaike; Kendra P Rumbaugh
Journal:  J Pathog       Date:  2014-06-25

5.  Antimicrobial susceptibility pattern of bacterial isolates from wound infection and their sensitivity to alternative topical agents at Jimma University Specialized Hospital, South-West Ethiopia.

Authors:  Mohammedaman Mama; Alemseged Abdissa; Tsegaye Sewunet
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-04-14       Impact factor: 3.944

6.  Effects of Selected Egyptian Honeys on the Cellular Ultrastructure and the Gene Expression Profile of Escherichia coli.

Authors:  Reham Wasfi; Walid F Elkhatib; Ahmed S Khairalla
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.